Vinpocetine Exerts Neuroprotective Effects via Downregulating α-Syn in Rotenone-induced Cellular Models of Parkinson's Disease

被引:0
作者
Ji, Meng [1 ]
Xu, Ji-Hua [1 ]
Mi, He-Yin [1 ]
Jiang, Peng [1 ]
Li, Yue [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Neurol, Beijing 100020, Peoples R China
关键词
Parkinson's disease; Vinpocetine; alpha-synuclein; Cytotoxicity; Dopaminergic; Polyvinylidene fluoride; ISCHEMIC-STROKE;
D O I
10.2174/0115701808274204231012111936
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: Vinpocetine (Vinp), a derivative of alkaloid vincristine with anti-inflammatory and antioxidant effects, has been shown to have neuroprotective effects in Parkinson's disease (PD). Its role and mechanisms, however, are not fully understood. Therefore, the aim of this study was to investigate the effects and possible mechanisms of Vinp on PD cells.Methods: SH-SY5Y cells were treated with Vinp and then with rotenone to induce a cellular model of PD. The proliferation level and apoptosis rate of SH-SY5Y cells after different treatments were detected by MTT and flow cytometry assays, respectively. Western blot was used to determine the relative protein expression of alpha-Synuclein (alpha-Syn) in differently treated cells. Additionally, commercial kits and ELISA were used to determine oxidative stress-related indicators (superoxide dismutase (SOD), malondialdehyde (MDA), and reactive oxygen species (ROS)) and inflammatory factors (tumor necrosis factor alpha [TNF-alpha], interleukin-5 (IL-5), and interleukin-1 beta (IL-1 beta)) in SH-SY5Y cells after different treatments, respectively.Results: Vinp at different concentrations (5, 10, and 50 mu M) had no significant effect on the proliferation and apoptosis of SH-SY5Y cells. For rotenone-induced SH-SY5Y cells, Vinp pretreatment could significantly reduce alpha-Syn expression, increased cell viability and decreased apoptosis, oxidative stress (downregulation of ROS and MDA levels and upregulation of SOD activity) and inflammation (increased levels of TNF-alpha, IL-5, and IL-1 beta). In contrast, overexpression of alpha-Syn in SH-SY5Y cells with Vinp pretreatment and rotenone induction partially reversed the aforementioned protective effects of Vinp, causing a decrease in proliferation, an increase in apoptosis rate, inflammation, and oxidative stress.Conclusion: Vinp exerted neuroprotective effects by downregulating alpha-Syn to promote proliferation, inhibit apoptosis, and inhibit oxidative stress and inflammation in rotenone-induced SH-SY5Y cells.
引用
收藏
页码:3060 / 3067
页数:8
相关论文
共 39 条
  • [11] Environmental exposure to metals and the development of tauopathies, synucleinopathies, and TDP-43 proteinopathies: A systematic evidence map protocol
    Hester, Kirstin
    Kirrane, Ellen
    Anderson, Timothy
    Kulikowski, Nichole
    Simmons, Jane Ellen
    Lehmann, David M.
    [J]. ENVIRONMENT INTERNATIONAL, 2022, 169
  • [12] Desulfovibrio bacteria enhance alpha-synuclein aggregation in a Caenorhabditis elegans model of Parkinson's disease
    Huynh, Vy A.
    Takala, Timo M.
    Murros, Kari E.
    Diwedi, Bidhi
    Saris, Per E. J.
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [13] Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and a-synuclein expressions in rats
    Ishola, I. O.
    Awogbindin, I. O.
    Olubodun-Obadun, T. G.
    Olajiga, A. E.
    Adeyemi, O. O.
    [J]. NEUROTOXICOLOGY, 2023, 96 : 37 - 52
  • [14] Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation
    Ishola, Ismail O.
    Akinyede, A. A.
    Adeluwa, T. P.
    Micah, C.
    [J]. METABOLIC BRAIN DISEASE, 2018, 33 (05) : 1493 - 1500
  • [15] Diagnostic biomarkers for Parkinson's disease: focus on a-synuclein in cerebrospinal fluid
    Kalia, Lorraine V.
    [J]. PARKINSONISM & RELATED DISORDERS, 2019, 59 : 21 - 25
  • [16] Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment
    Kalsoom, Iqra
    Wang, Yuanhao
    Li, Bo
    Wen, Hongliang
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (20) : 1959 - 1974
  • [17] The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease
    Karuppagounder, Senthilkumar S.
    Wang, Hu
    Kelly, Terence
    Rush, Roger
    Nguyen, Richard
    Bisen, Shivani
    Yamashita, Yoko
    Sloan, Nicholas
    Dang, Brianna
    Sigmon, Alexander
    Lee, Hyeun Woo
    Lee, Shirley Marino
    Watkins, Leslie
    Kim, Erica
    Brahmachari, Saurav
    Kumar, Manoj
    Werner, Milton H.
    Dawson, Ted M.
    Dawson, Valina L.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (679)
  • [18] The potential role of miR-124-3p in tumorigenesis and other related diseases
    Li, Qian
    Liu, Shuqing
    Yan, Jinsong
    Sun, Ming-Zhong
    Greenaway, Frederick T.
    [J]. MOLECULAR BIOLOGY REPORTS, 2021, 48 (04) : 3579 - 3591
  • [19] Exploration of the ?-syn/T199678/miR-519-3p/KLF9 pathway in a PD-related ?-syn pathology
    Lin, Danyu
    Li, Yao
    Huang, Kaixun
    Chen, Ying
    Jing, Xiuna
    Liang, Yanran
    Bu, Lulu
    Peng, Sudan
    Zeng, Shaowei
    Asakawa, Tetsuya
    Tao, Enxiang
    [J]. BRAIN RESEARCH BULLETIN, 2022, 186 : 50 - 61
  • [20] Ndfip1 Prevents Rotenone-Induced Neurotoxicity and Upregulation of α-Synuclein in SH-SY5Y Cells
    Liu, Xin
    Qu, Le
    Zhang, Na
    Yu, Xiaoqi
    Xiao, Zhixin
    Song, Limei
    Xie, Junxia
    Xu, Huamin
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 13